(IN BRIEF) GSK has signed an exclusive global licensing agreement with Empirico Inc. for EMP-012, a first-in-class siRNA candidate currently in Phase I trials for chronic obstructive pulmonary disease (COPD). EMP-012 targets a distinct inflammatory pathway, offering potential therapeutic benefit … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biologics, Chronic obstructive pulmonary disease, COPD, drug development, EMP-012, Empirico, gene expression, genetic medicine, GSK, GSK Acquires Global Rights to Empirico’s siRNA Candidate EMP-012 for Chronic Obstructive Pulmonary Disease, GSK and Empirico Partner on First-in-Class siRNA Therapy EMP-012 to Address Unmet Needs in COPD, Healthcare Innovation, inflammation, inflammation pathway, Kaivan Khavandi, licensing agreement, oligonucleotide therapeutics, Omri Gottesman, Phase I clinical trial, precision medicine, respiratory diseases, respiratory pipeline, siRNA, type 2 inflammation
(IN BRIEF) Boehringer Ingelheim has entered into a global collaboration and licensing agreement with Palatin Technologies to develop melanocortin receptor agonists as a new treatment for retinal diseases, beginning with diabetic retinopathy and diabetic macular edema. The approach targets inflammation, … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged biopharmaceutical collaboration, Boehringer Ingelheim, Carl Spana, diabetic macular edema, diabetic retinopathy, eye health innovation, inflammation, licensing agreement, melanocortin receptor agonists, neurodegeneration, Palatin Technologies, parttnership, Remko Bakker, Retinal Disease Treatment, vascular dysfunction, Vision Preservation, €280 million milestone payments
(IN BRIEF) GSK has entered into a multi-programme development and licensing agreement with Hengrui Pharma to advance up to 12 innovative therapies, including HRS-9821, a potentially best-in-class PDE3/4 inhibitor currently in clinical trials for COPD. The deal includes $500 million … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged AI-era medicine, biopharma partnership, Chronic obstructive pulmonary disease, clinical development, cloud healthcare, COPD treatment, drug innovation, drug pipeline, dry powder inhaler, Frank Jiang, global health, GSK, Hart-Scott-Rodino Act, Hengrui Pharma, HRS-9821, immunology, inflammation, licensing agreement, milestone payments, novel therapeutics, oncology, partnership, PDE3/4 inhibitor, pharmaceutical collaboration, phase I trials, respiratory medicine, Tony Wood
(IN BRIEF) An international team of researchers, including Empa scientists, is developing nanozymes to treat inflammation during pregnancy without harming the mother or fetus. These tiny particles, which have enzyme-like properties, could provide a safer alternative to traditional medications. Initial … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged anti-inflammatory, antibacterial, biotechnology, Empa, Empa research, fetal health, Healthcare Innovation, human placental tissue, inflammation, maternal health, nanomedicines, nanotechnology, nanozymes, Nikolaos Tagaras, placenta chip, placental barrier, pregnancy complications, pregnancy research, prenatal care, safe treatment, Swiss National Science Foundation, Tina Bürki
(IN BRIEF) A new UK research network led by the University of Southampton is investigating how the gut microbiome influences the brain and immune system. With £4.5 million in BBSRC funding, the four-year project brings together scientists from Southampton, Cambridge, … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged ADHD, Alzheimer's, Anne Ferguson-Smith, autism, BBSRC, brain-gut connection, dementia, diet and mental resilience, gut health, gut microbiome, gut-brain axis, healthspan, immune system, inflammation, Jessica Teeling, Jonathan Swann, King’s College London, lifestyle and cognition, mental health, microbiome research, mood disorders, neurodegenerative disease, neuroinflammation, neuroscience research, Parkinson's disease, Quadram Institute, UK science funding, University of Cambridge, University of Southampton
(PRESS RELEASE) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced an exclusive worldwide collaboration agreement signed with IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and … Read the full press release
Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key role in the immune response that is triggered by influenza infections. The molecule, a so-called mini viral RNA, is capable … Read the full press release
EXETER, 15-Jan-2018 — /EuropaWire/ — Scientists have discovered that the same plant used by indigenous people on Borneo is also used by wild orangutans to treat joint and muscle inflammation. Borneo Nature Foundation scientists have been observing wild Bornean orangutans in … Read the full press release
Posted in Education, Science, Technology, United Kingdom
Tagged Borneo, Borneo Nature Foundation, Dr Helen Morrogh-Bernard, Dr. Ivona Foitová, Dracaena cantleyi, Gadjah Mada University, inflammation, joint and muscle inflammation, Masaryk University, orangutans, Sabangau Forest, Self Medication, University of Exeter, wild orangutans in Borneo
Clinicians at the University Hospital Erlangen show how a new laser-based imaging technique termed MSOT can detect inflammation more accurately than current non-invasive diagnostic procedures and thereby help reduce the burden to patients MUNICH, 30-Mar-2017 — /EuropaWire/ — Ulcerative colitis … Read the full press release
Posted in France, Germany, Healthcare, Italy, Netherlands, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Christian Wiest, Clinicians, Crohn's disease, Crohn's disease patients, detection of melanoma metastasis, diagnosis, diagnostic imaging, Dr. Ferdinand Knieling, hemoglobin values, IBD, inflammation, inflammatory bowel disease, intestinal mucosa, invasive endoscopy procedure, iThera Medical, laser light, laser-based imaging technique, medical device, medical imaging, MSOT, MSOT technology, Multspectral Optoacoustic Tomography, new diagnostic imaging modality, New England Journal of Medicine, non-invasive assessment, optoacoustic, optoacoustic imaging, photoacoustic, Prof. Dr. Maximilian Waldner, sentinel lymph nodes, suspicious breast lesions, Ulcerative colitis, ultrasound, University Hospital Erlangen
Using a combination of newly developed methods, researchers led by LMU immunologist Veit Hornung have defined a previously unknown pathway that triggers inflammation. MUNICH, 04-Apr-2016 — /EuropaWire/ — The immune system in vertebrates is capable of distinguishing “self” from “non-self” components, … Read the full press release
Posted in Education, Germany, Healthcare, Science
Tagged Immunobiochemistry, inflammation, LMU, Moritz Gaidt, Veit Hornung
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?